Ildong Pharm


International Apex
Concise Prescribing Info
Pemetrexed disodium hemipentahydrate
Initial treatment of patients w/ locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) & malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curative surgery in combination w/ cisplatin. Maintenance treatment of locally advanced or metastatic NSCLC whose disease has not progressed after 4 cycles of platinum-based 1st-line chemotherapy. As single agent for locally advanced or metastatic NSCLC after prior chemotherapy.
Dosage/Direction for Use
Combination w/ cisplatin for nonsquamous NSCLC or malignant pleural mesothelioma 500 mg/m2 as IV infusion over 10 min on day 1 of each 21-day cycle or 75 mg/m2 infused over 2 hr beginning approx 30 min after the end of pemetrexed admin. Single-agent as maintenance following 1st-line or 2nd-line therapy 500 mg/m2 as IV infusion over 10 min on day 1 of each 21-day cycle. Premed regimen & concurrent medications Vit supplementation: Initiate folic acid 400-1,000 mcg orally once daily beginning 7 days before 1st dose of pemetrexed, continue during the full course of therapy & for 21 days after the last dose of pemetrexed. Administer vit B12 1 mg IM 1 wk prior to the 1st dose of pemetrexed & every 3 cycles thereafter. Subsequent vit B12 inj may be given the same day as treatment w/ pemetrexed. Corticosteroids: Administer dexamethasone 4 mg by PO bid before, the day of, & the day after pemetrexed admin.
Special Precautions
Initiate supplementation w/ oral folic acid & IM vit B12 prior to treatment to reduce the severity of hematologic & GI toxicity. Bone marrow suppression. Concomitant admin of NSAIDs. Do not initiate treatment unless ANC is ≥1,500 cells/mm3, platelet count is ≥100,000 cells/mm3 & CrCl ≥45 mL/min. Renal & hepatic impairment. Pregnancy & lactation. Childn. Elderly.
Adverse Reactions
Fatigue, stomatitis, pharyngitis, dyspnea, chest pain, and neuropathy. Rare cases of hepatitis, colitis, and intestinal pneumonitis have occurred; fatalities. Serious renal events, including acute renal failure. MI & cerebrovascular events. Radiation pneumonitis & recall. Hypersensitivity. Bone marrow depression, w/ leucopenia, anaemia. GI toxicity, nausea & vomiting, diarrhea & anorexia; mucositis. Reversible increases in liver enzyme values; weakness & malaise, fever, pain, headache, skin rashes, desquamation, arthralgia, muscle cramps, wt loss, dehydration, peripheral oedema, alopecia, increased sweating, taste disturbance & conjunctivitis.
Drug Interactions
Can decrease renal clearance w/ NSAIDs (Ibuprofen). Delayed clearance w/ probenecid.
ATC Classification
L01BA04 - pemetrexed ; Belongs to the class of antimetabolites, folic acid analogues. Used in the treatment of cancer.
Trexor lyo powd for infusion 500 mg
Trexor lyo powd for infusion 100 mg
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in